| Product Name |
Ivermectin EP Impurity G |
| Product Category | Impurities, Intermediates |
| Sub-Category | Heterocycles, Pharmaceutical Standards, Fine Chemicals, Chiral Standards |
| CAS No | 73162-95-5 |
| Catalog Number | GS.35.IVM.07 |
| Chemical Name/Synonyms | Ivermectin B1 Aglycon; (6R,13S,25R)-5-O-Demethyl-28-deoxy-6,28-epoxy-13-hydroxy-25-[(1S)-1-methylpropyl]-milbemycin B; [6R,13S,25R(S)]-5-O-Demethyl-28-deoxy-6,28-epoxy-13-hydroxy-25-(1-methylpropyl)-milbemycin B;Spiro[11,15-methano-2H,13H,17H-furo[4,3,2-pq][2,6]benzodioxacyclooctadecin-13,2'-[2H]pyran] Milbemycin B Deriv.; 22,23-Dihydroavermectin B1a Aglycon; H2B1a aglycone |
| Molecular Weight | 586.76 |
| Molecular Formula | C34H50O8 |
| Purity | NLT 95 % |
| Appearance | White to Pale Yellow Solid |
| Solubility | Chloroform, Methanol |
| Applications | vermectin B1a aglycone is an acid degradation product produced by hydrolysis of the disaccharide unit of ivermectin. It can inhibit nematode larval development, but does not cause paralytic activity. |
| Inventory Status | Ready Stock Please as a distributor to view package sizes and prices |